Annika Elmhorn‐Rosenborg

Response to 2-Chlorodeoxyadenosine in Patients with B-Cell Chronic Lymphocytic Leukemia Resistant to Fludarabine

Gunnar Juliusson, Annika Elmhorn‐Rosenborg, Jan Liliemark · New England Journal of Medicine · 1992 · 127 citations · Full text

Medicine, Oncology, Pharmacology +14

P-Glycoprotein Inhibitor Valspodar (PSC 833) Increases the Intracellular Concentrations of Daunorubicin In Vivo in Patients With P-Glycoprotein–Positive Acute Myeloid Leukemia

Ulf Tidefelt, Jan Liliemark, Astrid Gruber et al. · Journal of Clinical Oncology · 2000 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +17

Expression of glutathione transferase pi as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia.

Ulf Tidefelt, Annika Elmhorn‐Rosenborg, Christer Paul et al. · PubMed · 1992 · 96 citations

Medicine, Hematology, Oncology +14

Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia.

Gunnar Juliusson, Ilse Christiansen, Mogens Hansen et al. · Journal of Clinical Oncology · 1996 · 80 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1

Olle Ringd n, Mats Remberger, Stefan Carlens et al. · Transplantation · 1998 · 70 citations

Life Sciences, Hematology, Immunology +17